Product Information
ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.1051 per EA under NDC 60505285009. Its NADAC has been published 156 times since Oct 11, 2023.
FDA first approved this application on Jul 18, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Apotex Corp.NDC
60505285009
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALFUZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079013FDA Approved
7/18/2011
TE Code
AB
On Market Since
9/8/2023
Pharmacological Classes
Price Statistics
The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 156 times since Oct 11, 2023, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1051 per EA |
|---|---|
| All-time high | $0.1516 (Dec 13, 2023) |
| All-time low | $0.1034 (Jan 22, 2025) |
| 52-week high | $0.1121 |
| 52-week low | $0.1051 |
| Median price | $0.1090 |
| Average price | $0.1124 |
| Largest weekly change | +32.0% (Nov 22, 2023) |
| Weeks tracked | 156 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alfuzosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Apotex Corp., is $0.1051 per EA (NDC 60505285009), effective Sep 30, 2026.
How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 7.2%. It has been tracked across 156 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?
Since Oct 11, 2023, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.1516 (Dec 13, 2023), with a median of $0.1090 per EA.
Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALFUZOSIN HCL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?
ALFUZOSIN HCL ER 10 MG TABLET (NDC 60505285009) is labeled by Apotex Corp., and CMS classifies it as a generic product.